Invest in Life
IVAO — reliable partner of investors, scientists, entrepreneurs and experts
in the world of biotechnology, pharmaceuticals and medicine
IVAO News
Get the most relevant news, establish new social connections and communicate with world-known experts.

It’s not an easy environment for health-care investors, with the sector front and center of political debates, but a bigger concern might be stemming from a key regulator: the U.S. Food and Drug Administration.

Company working on a number of agreements in parallel to ensure broad and equitable supply of the vaccine throughout the world at no profit during the pandemic.
First agreements to supply at least 400 million doses; Company has total capacity sourced for one billion doses through 2020 and into 2021; continues to increase capacity further.
More than $1bn US BARDA investment to support development and production of the vaccine.

Microbiologists have isolated antibodies from the plasma of people who have had COVID-19, which neutralize the coronavirus. Tests have so far passed only on monkeys, ahead – clinical trials on humans.

Ventilators sent by Russia to the United States of the same model that reportedly caused two deadly fires in Russian hospitals were never used in the United States, the U.S. Federal Emergency Management Agency said on Tuesday.

Events and Conferences
Biohacker Summit 2020 Amsterdam Netherlands, Amsterdam
IFA 15th Global Conference on Ageing Canada, Toronto
Database IVAO
The database presents the most promising opportunities for investing your capital.